Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

A novel variant of PHEX in a Korean family with X-linked hypophosphatemic rickets

  • Kim, Sejin (Department of Pediatrics, Dong-A University Hospital) ;
  • Kim, Sungsoo (Department of Orthopedic Surgery, Dong-A University Hospital) ;
  • Kim, Namhee (Department of Laboratory Medicine, Dong-A University Hospital)
  • Received : 2021.12.14
  • Accepted : 2022.05.08
  • Published : 2022.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

X-linked dominant hypophosphatemic rickets are the most common form of familial hypophosphatemic rickets resulting from hypophosphatemia caused by renal phosphate wasting, which in turn is a result of loss-of-function mutations in PHEX. Herein, we report a 39-year-old female with short stature and skeletal deformities and 12-month-old asymptomatic daughter. The female has a history of multiple surgical treatments because of lower limb deformities. Her biochemical findings revealed low serum phosphorus levels with elevated serum alkaline phosphatase activity and normal serum calcium levels, suggesting presence of hypophosphatemic rickets. To identify the molecular causes, we used a multigene testing panel and found a mutation, c.667dup (p.Asp223GlyfsTer15), in PHEX gene. To the best of our knowledge, this is a novel mutation. A heterozygous form of the same variant was detected in daughter, who showed no typical symptoms such as bow legs, frontal bossing, or waddling gate, but presented early signs of impaired mineralization in both X-ray and biochemical findings. The daughter was initiated onto early medical treatment with oral phosphate supplementation and an active vitamin D analog. Because the daughter was genetically diagnosed based on a family history before the onset of symptoms, appropriate medical management was possible from early infancy.

Keywords

Acknowledgement

This work was supported by the Dong-A University research fund in 2021.

References

  1. Ichikawa S, Traxler EA, Estwick SA, Curry LR, Johnson ML, Sorenson AH, et al. Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets. Bone 2008;43:663-6. https://doi.org/10.1016/j.bone.2008.06.002
  2. Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, Cowell CT, et al. Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 2001;86:3889-99. https://doi.org/10.1210/jc.86.8.3889
  3. Song HR, Park JW, Cho DY, Yang JH, Yoon HR, Jung SC. PHEX gene mutations and genotype-phenotype analysis of Korean patients with hypophosphatemic rickets. J Korean Med Sci 2007;22:981-6. https://doi.org/10.3346/jkms.2007.22.6.981
  4. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24. https://doi.org/10.1038/gim.2015.30
  5. Yang M, Kim J, Yang A, Jang J, Jeon TY, Cho SY, et al. A novel de novo mosaic mutation in PHEX in a Korean patient with hypophosphatemic rickets. Ann Pediatr Endocrinol Metab 2018;23:229-34. https://doi.org/10.6065/apem.2018.23.4.229
  6. Jo HY, Shin JH, Kim HY, Kim YM, Lee H, Bae MH, et al. Identification of a novel variant in the PHEX gene using targeted gene panel sequencing in a 24-month-old boy with hypophosphatemic rickets. Ann Pediatr Endocrinol Metab 2020;25:63-7. https://doi.org/10.6065/apem.2020.25.1.63
  7. Kim J, Yang KH, Nam JS, Choi JR, Song J, Chang M, et al. A novel PHEX mutation in a Korean patient with sporadic hypophosphatemic rickets. Ann Clin Lab Sci 2009;39:182-7.
  8. Jeong IH, Yoo JH, Kim N. A pathogenic PHEX variant (c.1483-1G>C) in a Korean patient with X-linked hypophosphatemic rickets. Ann Pediatr Endocrinol Metab 2021;26:130-3. https://doi.org/10.6065/apem.2040186.093
  9. Makitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E. Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 2003;88:3591-7. https://doi.org/10.1210/jc.2003-030036
  10. Quinlan C, Guegan K, Offiah A, Neill RO, Hiorns MP, Ellard S, et al. Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment. Pediatr Nephrol 2012;27:581-8. https://doi.org/10.1007/s00467-011-2046-z
  11. Cho HY, Lee BH, Kang JH, Ha IS, Cheong HI, Choi Y. A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res 2005;58:329-33. https://doi.org/10.1203/01.PDR.0000169983.40758.7B
  12. Cheon CK, Lee HS, Kim SY, Kwak MJ, Kim GH, Yoo HW. A novel de novo mutation within PHEX gene in a young girl with hypophosphatemic rickets and review of literature. Ann Pediatr Endocrinol Metab 2014;19:36-41. https://doi.org/10.6065/apem.2014.19.1.36
  13. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res 2011;26:1381-8. Erratum in: J Bone Miner Res 2015;30:394. https://doi.org/10.1002/jbmr.340
  14. Namba N, Kubota T, Muroya K, Tanaka H, Kanematsu M, Kojima M, et al. Safety and efficacy of burosumab in pediatric patients with X-linked hypophosphatemia: a phase 3/4 open-label trial. J Endocr Soc 2022;6:bvac021. https://doi.org/10.1210/jendso/bvac021